Amanda Schulman

Amanda Schulman is a Senior Clinical Operations Lead at Sarepta Therapeutics, responsible for managing global gene therapy clinical trials for LGMD and DMD since July 2020. With a comprehensive background in clinical operations, Amanda has held various roles including Clinical Operations Lead, and Senior Clinical Trial Associate, focusing on study and site management across multiple trials. Prior experience includes serving as a Clinical Research Coordinator at Boston Medical Center, where Amanda managed numerous cancer clinical trials, and as an In-House Compliance & Monitoring Coordinator at the UW Carbone Cancer Center, providing guidance on FDA and IRB requirements. Amanda holds a Master of Science in Clinical Research from Boston University and a Bachelor's Degree in Neurobiology and Neurosciences from the University of Wisconsin-Madison.